Companies: 10,795·Total market cap: $144.5T
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

TEVJFOTCHealthcare● Active
$30.34
+$0.15(+0.50%)
Market Cap$35.3B
P/E Ratio
52W High$32.84
52W Low$14
Overview

Teva Pharmaceutical Industries Limited (TEVJF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TEVJF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$1.38tevjf eps ttm · tevjf earnings per shareEarnings history
PE Ratio (TTM)22.0×tevjf pe ratio ttm · tevjf price to earningsPE Ratio deep dive
Revenue (TTM)$17.3Btevjf revenue ttm · tevjf annual revenueFull revenue history
Dividend Yield5.74%does tevjf pay dividends · tevjf dividend yieldDividend history
Shares Outstanding1.15Btevjf shares outstanding · tevjf floatShares outstanding history
Next EarningsAug 5, 2026Est.tevjf earnings date · tevjf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$18.68B▲ +12.92% YoY
202320242025
teva pharmaceutical industries limited revenue · tevjf revenue 2025
FY 2025Net Income$1.53B▲ +193.19% YoY
202320242025
teva pharmaceutical industries limited net income · tevjf profit 2025
FY 2025EPS$1.33▲ +191.72% YoY
202320242025
tevjf eps · teva pharmaceutical industries limited earnings per share 2025
TTM:Revenue: $17.35BNet Income: $1.58BEPS: $1.38View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold39 analystsis tevjf a buy · tevjf analyst rating
Strong Buy
0
Buy
12
Hold
23
Sell
4
Strong Sell
0
12-Month Price Target
$Low
$30.34Current
$Avg Target
$High
tevjf price target · tevjf 12 month forecast

Total: 39 · Buy rate: 30.8%

Stock Performance

Full History
1D+0.50%
1W+0.50%
1M+3.94%
3M+6.98%
YTD+6.05%
1Y+70.45%
5Y+188.95%

About Teva Pharmaceutical Industries Limited

CEORichard D. Francis
IPO DateJun 18, 2010
Employees37,000
CountryIL

Teva Pharmaceutical Industries Limited a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North Ameri…

what is teva pharmaceutical industries limited · tevjf stock overview · teva pharmaceutical industries limited company profile · who is teva pharmaceutical industries limited ceo · tevjf OTC · teva pharmaceutical industries limited headquarters · teva pharmaceutical industries limited business segments

About Stock Overview & Key Data

Teva Pharmaceutical Industries Limited (TEVJF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jun 18, 2010. As of the latest trading session, TEVJF stock price is $30.34, with a market capitalization of $35.3B. The stock has returned +70.45% over the past 12 months and +6.05% year-to-date.

According to 39 Wall Street analysts, the consensus rating for Teva Pharmaceutical Industries Limited stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Teva Pharmaceutical Industries Limited reported revenue of $18.7B and net income of $1.5B. For detailed data — including Teva Pharmaceutical Industries Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Teva Pharmaceutical Industries Limited (TEVJF) stock price is $30.34. The stock is traded on OTC under the ticker symbol TEVJF. The 52-week range is $14.00 – $32.84.

TEVJF stock priceTEVJF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice